Journal of Digestive Cancer Research 2023; 11(1): 58-60
Published online April 20, 2023
https://doi.org/10.52927/jdcr.2023.11.1.58
© Korean Society of Gastrointestinal Cancer Research
Correspondence to :
Eun Sun Kim, E-mail: silverkes@naver.com, https://orcid.org/0000-0003-1820-459X
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0). which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
QUESTION: A 48-year-old man visited our hospital complaining of abdominal pain, nausea, and general weakness. The patient has no special medical history other than the fact that he was treated for 2019 coronavirus (COVID-19) a month ago and receiving chemotherapy for colorectal cancer. He received conservative treatment at the time of treatment for COVID-19, and after receiving hospitalization for a week, his symptoms improved and he was discharged. Two weeks later, when he visited the pulmonology department at our hospital, he complained of nausea along with intermittent pain in the epigastric region, and was referred to the gastroenterology and hepatology department.
There were no specific findings on blood tests and computed tomography scans of the chest and abdomen. Therefore, we performed esophagogastroduodenoscopy (Fig. 1) and Total colonoscopy (Fig. 2) to try to determine if there were any other problems. However there were no specific findings other than traces of gastric ulcer on stomach body in the two endoscopic examinations, and the patient continued to complain of intermittent symptoms.
What is the diagnosis for this case?
ANSWER: Long covid syndrome.
REVIEW: During the COVID-2019 pandemic, numerous patients recovered from severe coronavirus 2 acute respiratory syndrome (SARS-Cov-2) infections. However, even after recovery, patients with a wide variety of symptoms have been reported, and they are expressed in terms such as ‘Long Covid’, ‘Post-COVID condition’, and ‘Post acute sequalae of SARS-Cov-2 infection’. These symptoms may appear similarly after recovery from other sepsis or viral infections. In particular, digestive cancer patients may have more connections with Long Covid symptoms due to surgery, chemotherapy, poor physical condition, etc., and to cope with these patients, we want to find out about the symptoms suspected of Long Covid [1].
COVID-19 appears 4 weeks after infection, and
Fatigue (13–87%), shortness of breath (10–71%), chest pain (12–44%), and cough (17–34%) are common as the main Long Covid symptoms. Mental sequelae such as anxiety (22%), depression (23%), post-traumatic stress syndrome (24%), memory loss (18–21%), attention deficit (16%) may also suffer. In rare cases, symptoms such as loss of smell, joint pain, headache, dry mouth, rhinitis, loss of taste, loss of appetite, dizziness, muscle pain, insomnia, voice change, hair loss, sweating, decreased libido, and diarrhea are experienced. About half of patients experience a decrease in quality of life [3].
Nausea and diarrhea symptoms may appear as digestive symptoms among the symptoms of Long Covid, and they gradually improve. However, if symptoms worsen or develop new, antibiotic-induced diarrhea or
Even in treating digestive cancer patients, it is necessary for medical staff to pay attention to the difficulties that patients experience with Long Covid symptoms and the degree to which they cause difficulties in daily life, and to support them so that they can gradually recover and to perform rehabilitation if necessary. We need to ensure that appropriate action is taken.
No potential conflict of interest relevant to this article was
reported.
Conceptualization: Eun Sun Kim. Data acquisition: Eun Sun Kim. Formal analysis: Eun Sun Kim. Supervision: Eun Sun Kim. Writing—original draft: Young Cheon Ra. Writing—review & editing: Young Cheon Ra.
Journal of Digestive Cancer Research 2023; 11(1): 58-60
Published online April 20, 2023 https://doi.org/10.52927/jdcr.2023.11.1.58
Copyright © Korean Society of Gastrointestinal Cancer Research.
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
Correspondence to:Eun Sun Kim, E-mail: silverkes@naver.com, https://orcid.org/0000-0003-1820-459X
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0). which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
QUESTION: A 48-year-old man visited our hospital complaining of abdominal pain, nausea, and general weakness. The patient has no special medical history other than the fact that he was treated for 2019 coronavirus (COVID-19) a month ago and receiving chemotherapy for colorectal cancer. He received conservative treatment at the time of treatment for COVID-19, and after receiving hospitalization for a week, his symptoms improved and he was discharged. Two weeks later, when he visited the pulmonology department at our hospital, he complained of nausea along with intermittent pain in the epigastric region, and was referred to the gastroenterology and hepatology department.
There were no specific findings on blood tests and computed tomography scans of the chest and abdomen. Therefore, we performed esophagogastroduodenoscopy (Fig. 1) and Total colonoscopy (Fig. 2) to try to determine if there were any other problems. However there were no specific findings other than traces of gastric ulcer on stomach body in the two endoscopic examinations, and the patient continued to complain of intermittent symptoms.
What is the diagnosis for this case?
ANSWER: Long covid syndrome.
REVIEW: During the COVID-2019 pandemic, numerous patients recovered from severe coronavirus 2 acute respiratory syndrome (SARS-Cov-2) infections. However, even after recovery, patients with a wide variety of symptoms have been reported, and they are expressed in terms such as ‘Long Covid’, ‘Post-COVID condition’, and ‘Post acute sequalae of SARS-Cov-2 infection’. These symptoms may appear similarly after recovery from other sepsis or viral infections. In particular, digestive cancer patients may have more connections with Long Covid symptoms due to surgery, chemotherapy, poor physical condition, etc., and to cope with these patients, we want to find out about the symptoms suspected of Long Covid [1].
COVID-19 appears 4 weeks after infection, and
Fatigue (13–87%), shortness of breath (10–71%), chest pain (12–44%), and cough (17–34%) are common as the main Long Covid symptoms. Mental sequelae such as anxiety (22%), depression (23%), post-traumatic stress syndrome (24%), memory loss (18–21%), attention deficit (16%) may also suffer. In rare cases, symptoms such as loss of smell, joint pain, headache, dry mouth, rhinitis, loss of taste, loss of appetite, dizziness, muscle pain, insomnia, voice change, hair loss, sweating, decreased libido, and diarrhea are experienced. About half of patients experience a decrease in quality of life [3].
Nausea and diarrhea symptoms may appear as digestive symptoms among the symptoms of Long Covid, and they gradually improve. However, if symptoms worsen or develop new, antibiotic-induced diarrhea or
Even in treating digestive cancer patients, it is necessary for medical staff to pay attention to the difficulties that patients experience with Long Covid symptoms and the degree to which they cause difficulties in daily life, and to support them so that they can gradually recover and to perform rehabilitation if necessary. We need to ensure that appropriate action is taken.
None.
No potential conflict of interest relevant to this article was
reported.
Conceptualization: Eun Sun Kim. Data acquisition: Eun Sun Kim. Formal analysis: Eun Sun Kim. Supervision: Eun Sun Kim. Writing—original draft: Young Cheon Ra. Writing—review & editing: Young Cheon Ra.